cancer or CVD, and subsequently by the presence of comorbid cancer and CVD. Abbreviation: CVD, cardiovascular disease. Patient Characteristics Baseline characteristics of patients with COVID-19 are shown in Table 1 . Patients with COVID
Search Results
Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease
Sarju Ganatra, Sourbha S. Dani, Robert Redd, Kimberly Rieger-Christ, Rushin Patel, Rohan Parikh, Aarti Asnani, Vigyan Bang, Katherine Shreyder, Simarjeet S. Brar, Amitoj Singh, Dhruv S. Kazi, Avirup Guha, Salim S. Hayek, Ana Barac, Krishna S. Gunturu, Corrine Zarwan, Anne C. Mosenthal, Shakeeb A. Yunus, Amudha Kumar, Jaymin M. Patel, Richard D. Patten, David M. Venesy, Sachin P. Shah, Frederic S. Resnic, Anju Nohria, and Suzanne J. Baron
A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers
Kate Watabayashi, Jordan Steelquist, Karen A. Overstreet, Anthony Leahy, Erin Bradshaw, Kathleen D. Gallagher, Alan J. Balch, Rebecca Lobb, Laura Lavell, Hannah Linden, Scott D. Ramsey, and Veena Shankaran
–caregiver dyads to an oncology financial navigation program. We describe the demographic and financial characteristics of enrolled subjects, the assistance provided to participants by our navigation partners, participants’ overall satisfaction with the program
Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures
Yuqi Zhang, Marcelo Cerullo, Andrew Esposito, and Vishnukamal Golla
.0%), qualified for Medicare disproportionate share hospital payments (n=972; 90.4%) and located in a county with a metropolitan population >250,000 (n=782; 72.7%) ( Table 1 ). Table 1. Characteristics of ACS-CoC Accredited Hospitals by Price Disclosures
Abstracts From the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™
into clinical care paths. Further, cancer treatment is becoming increasingly personalized to the patient and tumor characteristics, thus increasing the complexity of decision-making. Methods: We developed a method to model guideline recommendations
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry
Danielle N. Blunt, Liam Smyth, Chenthila Nagamuthu, Evgenia Gatov, Ruth Croxford, Lee Mozessohn, and Matthew C. Cheung
with >15 days from diagnosis to treatment initiation (DTI) had lower-risk characteristics and improved event-free survival (EFS) at 24 months from diagnosis compared with patients treated more urgently. Furthermore, a retrospective, observational study
Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor–Induced Hepatitis
Michael Li, Danny Wong, Jordan S. Sack, Alexander S. Vogel, F. Stephen Hodi, Lawrence Fong, Jennifer C. Lai, Shilpa Grover, and Stephen D. Zucker
characteristics and laboratory values were broadly similar between the 2 groups. There also was no difference between the groups regarding causative ICI regimen, laboratory values at the time of first grade 3–4 ALT elevation, laboratory values at the time of peak
Prevalence of Anemia and Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia in Patients With Gynecologic Cancer
Demetra Hypatia Hufnagel, Sumit Tushar Mehta, Chinyere Ezekwe, Alaina J. Brown, Alicia Beeghly-Fadiel, and Lauren Shore Prescott
version 3.4.4 (R Foundation for Statistical Computing). Univariate and multivariable regression were performed using SAS 9.4 (SAS Institute Inc) to evaluate the associations between clinical characteristics and anemia prevalence, evaluation, and treatment
Phase I Clinical Trial of Bendamustine and Bevacizumab for Patients With Advanced Cancer
Apostolia M. Tsimberidou, Alexandra M. Adamopoulos, Yang Ye, Sarina Piha-Paul, Filip Janku, Siqing Fu, David Hong, Gerald S. Falchook, Aung Naing, Jennifer Wheler, Adoneca Fortier, Razelle Kurzrock, and Kenneth R. Hess
date of last follow-up were censored on that date. The patient characteristics were analyzed using descriptive statistics. Survival functions were estimated using the Kaplan-Meier method. Results Demographics From July 2010 to December
Patterns of Palliative Care Consultation Among Elderly Patients With Cancer
Eric J. Roeland, Daniel P. Triplett, Rayna K. Matsuno, Isabel J. Boero, Lindsay Hwang, Heidi N. Yeung, Loren Mell, and James D. Murphy
after cancer diagnosis. Regional Covariates This study evaluated the association between the regional use of cancer-related palliative care and regional health care characteristics. Regional geography was evaluated at the level of hospital
Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database
Guru Subramanian Guru Murthy, Aniko Szabo, Laura Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Sameem Abedin, and Ehab Atallah
characteristics, type of malignancy, and survival duration; however, it did not provide information on patient symptoms, performance status, cytogenetics, MRD, treatment drugs, stem cell transplantation, or other prognostic factors. Selection criteria for this
